
    
      PROMPT (Prospective Registry of Multiplex Testing) is an Internet-based, patient-directed
      ascertainment study. It is a partnership between Memorial Sloan Kettering, University of
      Pennsylvania, Mayo Clinic, and Dana Farber Cancer Institute in collaboration with Ambry
      Genetics, GeneDx, Myriad Genetics, Pathway Genomics, and Quest Laboratories (5 laboratories
      providing multiplex panel testing commercially).
    
  